olfactory receptor family 7 subfamily E member 14 pseudogeneGenealiases: OR11-5 · OR7E151P
Q-omics provides the consensus-scored OR7E14P profile across patient tissues and cancer cell-line models. OR7E14P expression is associated with patient survival in 25 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, OR7E14P is differentially expressed in 16, with the highest sampling consensus in HNSC. Additionally, OR7E14P RNA expression shows 14,019 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight KIRC, HNSC, and TGCT as cancer lineages where OR7E14P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR7E14P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR7E14P survival associations across molecular data types. OR7E14P RNA expression shows survival associations in the most cancer types (25). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR7E14P RNA expression–survival associations across cancer types. High OR7E14P expression shows unfavorable associations in PAAD, but favorable associations in KIRC, KIRP, MESO, BRCA and OV. The KIRC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for OR7E14P RNA expression.
This table summarizes OR7E14P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 16. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for OR7E14P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OR7E14P shows lower tumor expression in HNSC, KIRP and KIRC and higher tumor expression in LUAD, THCA and UCEC. The HNSC box plot shows higher OR7E14P RNA expression in normal versus tumor tissue (log2 FC = −1.437, t-test p < 0.001).
This table shows molecular features associated with OR7E14P in patient tissues and cancer cell lines. In patient samples, OR7E14P shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set. In cancer cell lines, OR7E14P RNA and mutation anchors are most strongly linked to RNA-expression features, especially in NCI60_ALL.
